Company

Vision

AI.ble Therapeutics Inc. believes that people can live free from the fear of dementia,
by combining new ideas and AI technologies.

We’re developing a integrative digital platform to prevent, diagnose, manage and treat neuropsychiatric diseases,
hoping for more and more people can benefit from our service.

AIble in Media

Thumbnail
Thumbnail

History

2023

AugA patent registered in Taiwan for Speech-based dementia diagnosis

JunStarted a clinical trial to collect speech data in Mandarin with Show Chwan Memorial Hospital in Taiwan

MayA patent registered in Korea for cognitive-motor training program

MayAcquired GS Certification Level 1

AprA patent registered in Korea for speech-based dementia diagnosis (refined)

AprSelected for KISED 2023 Innovative Startup Package

MarSelected for KISA-DB Insurance Insuretech Startup Incubation Program

MarSelected for Shinhan Bank Square Bridge 2023 Incheon AC Program

MarA patent registered in Korea for drawing-based dementia diagnosis

FebContracted for a clinical trial with Show Chwan Memorial Hospital in Taiwan to collect speech data in Mandarin

2022

DecRaised Follow funding

DecStarted a clinical trial of "Cognimo" with the Catholic University of Korea Eunpyeong St. Mary's Hospital

DecStarted Spick PoC at Daekyo Newif senior care centers

SepSelected for Korea International Trade Association 2022 GSS Startup Program

AugSelected for the Ministry of Science and ICT K-Global AC Program

JulSelected for Daekyo x Kyobo Insurance Age-Tech Wave Open Innovation Program

JunAcquired GMP (Good Manufacturing Process) for Spick

AprSelected for the Ministry of Health and Welfare R&D Project

FebSelected for the Ministry of SMEs and Startups R&D project

2021

DecSelected for BE Health Ventures x SCMH AC Program in Taiwan

NovA U.S patent applied for speech-based dementia diagnosis

OctRaised Seed Funding

JulA patent registered in Korea for speech-based dementia diagnosis

JunSelected for Sports Industry Accelerating Program by Korea Sports Promotion Foundation

AprTop 6 finalist at D.Camp startup pitch competition

MarWon the first prize in ICT idea competition hosted by the Ministry of Science and ICT

FebAI.ble Therapeutics established

JanCompleted the 2nd clinical trial (1,300 subjects in 11 hospitals)

2020

Started the 2nd clinical trial

Completed the 1st clinical trial

2019

Started the 1st clinical trial to collect speech data

Completed the development of a speech-based dementia diagnosis algorithm

2018

Started the research and development of a speech-based dementia diagnosis

Members

Kim, Hyungjun (CEO)

Prof. Kim, Woojun (CSO)

The Catholic Univ. Of Korea Seoul St.Mary's Hospital

Cheon, Hosang (CXO)

UI·UX Expert

Prof. Kim, Jaewon (CTO)

Seoul National University Hospital

Prof. Lim, Junsik (CTO)

Gachon University

Shin, Youjin

Business Strategy

Chung, Jaehoon

Chief Engineer

Kim, Hyosun

Full-stack Engineer

Hong, Suhun

AI Engineer

Baek, Chaneun

AI Engineer

Advisory Group

Prof. Yang, Dongwon

The Catholic Univ. Of Korea Seoul St.Mary's Hospital
Seoul Metropolitan Center for Dementia

Prof. Shim, Yongsoo

The Catholic Univ. Of Korea Eunpyeong St.Mary's Hospital
Seoul Metropolitan Center for Dementia

Prof. Park, Jihye

The Catholic Univ. Of Korea Eunpyeong St.Mary's Hospital
Korean Society for NeuroRehabilitation